Send to

Choose Destination
Data Brief. 2015 Nov 5;5:888-92. doi: 10.1016/j.dib.2015.10.036. eCollection 2015 Dec.

Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations.

Author information

Department of Pathology, Center for Advanced Laboratory Medicine, University of California, San Diego Health Systems, San Diego, CA, USA.
Department of Anesthesiology and Critical Care Medicine, George Washington, University Medical Center, Washington, DC, USA.
Department of Pathology and ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, UT, USA.
Department of Pathology, University of Louisville, Louisville, KY, USA.
John T. Mather Memorial Hospital, Port Jefferson, NY, USA.
Phoenix Medical Group, Peoria, AZ, USA.
Center for Critical Care Nephrology Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.


This data in brief describes characteristics of chronic stable comorbid patients who were included in reference range studies of [IGFBP7]·[TIMP-2] "Reference Intervals of Urinary Acute Kidney Injury (AKI) Markers [IGFBP7]·[TIMP2] in Apparently Healthy Subjects and Chronic Comorbid Subjects without AKI" [1]. In order to determine the specificity of [IGFBP7]·[TIMP-2] for identifying patients at risk of developing AKI we studied a cohort with nine broad classification of disease who did not have AKI. Details regarding the population that was targeted for inclusion in the study are also described. Finally, we present data on the inclusion criteria for the healthy subjects used in this investigation to determine the reference range.


Acute kidney injury, Biomarkers, IGFBP7; Insulin-like growth factor-binding protein 7; Reference ranges; TIMP2; Tissue inhibitor of metalloproteinases-2

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center